Compare CELU & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CELU | CLRO |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 17.0M |
| IPO Year | 2019 | 2018 |
| Metric | CELU | CLRO |
|---|---|---|
| Price | $0.70 | $4.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 35.5K | ★ 1.7M |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $26,550,000.00 | ★ $46,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.59 |
| 52 Week Low | $0.56 | $2.71 |
| 52 Week High | $4.15 | $16.50 |
| Indicator | CELU | CLRO |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 45.61 |
| Support Level | $0.69 | $3.97 |
| Resistance Level | $0.85 | $4.98 |
| Average True Range (ATR) | 0.06 | 1.45 |
| MACD | 0.00 | -0.15 |
| Stochastic Oscillator | 66.20 | 13.15 |
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
ClearOne Inc is currently engaged in activities that consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance.